Cargando…
The clinical application of UGT1A1 pharmacogenetic testing: Gene-environment interactions
Over the past decade, the number of pharmacogenetic tests has increased considerably, allowing for the development of our knowledge of their clinical application. The uridine diphosphate glucuronosyltransferase 1A1 gene (UGT1A1) assay is an example of a pharmacogenetic test. Numerous variants have b...
Autores principales: | Marques, Sara Correia, Ikediobi, Ogechi N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525209/ https://www.ncbi.nlm.nih.gov/pubmed/20511137 http://dx.doi.org/10.1186/1479-7364-4-4-238 |
Ejemplares similares
-
Analysis of pharmacogenetic traits in two distinct South African populations
por: Ikediobi, Ogechi, et al.
Publicado: (2011) -
Pharmacogenetics of ugt genes in North African populations
por: Gaibar, M., et al.
Publicado: (2018) -
97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing
por: Varughese, Lisa A., et al.
Publicado: (2021) -
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1
por: de With, Mirjam, et al.
Publicado: (2023) -
UGT1A1 (TA)(n) Promoter Genotype: Diagnostic and Population Pharmacogenetic Marker in Serbia
por: Vukovic, M, et al.
Publicado: (2018)